Colorcon Ventures, the corporate venture fund of Colorcon, has invested in Apprentice.io, a provider of ‘intelligent manufacturing execution systems’ (MES) designed for the life sciences industry.
Apprentice offers an end-to-end platform with a suite of software designed to streamline batch-based manufacturing and remote collaboration. Its products address intelligent batch execution, augmented procedures and workflows, predictive resource management, and immersive training.
Ali Rajabi-Siahboomi, VP and Chief Innovation Officer at Colorcon, said: “Our customers are striving for faster times to market, improved manufacturing consistency, as well as business continuity through times of crisis. During COVID, demand for Apprentice has accelerated with several leading pharmaceutical manufacturers, as design weaknesses in legacy manufacturing systems were exposed. Based on the positive outcomes seen by industry participants, we anticipate a broader global adoption of Apprentice’s solutions.”
Angelo Stracquatanio, Apprentice’s founder and CEO, said: “We are excited to have Colorcon Ventures join us as a strategic investor on our mission to modernise pharmaceutical manufacturing and realise Pharma 4.0, with the objective of getting medicine to patients faster and safer. Colorcon’s global footprint and pharma relationships will be invaluable as we begin to expand our geographic reach.”
Colorcon Ventures joins the list of investors who also participated in Apprentice’s recently announced Series C, including Alkeon Capital Management, Insight Partners, Pacific West Bank, Silverton Partners, GFR Fund, and The Venture Reality Fund.
